Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Dam Larsen F, Jespersen S, Wejse C, Petersen E, Larsen CS. One-sixth of inpatients in a Danish infectious disease ward have imported diseases: A cross-sectional analysis. Travel Med Infect Dis 2017;20:43-48. [PMID: 29066404 DOI: 10.1016/j.tmaid.2017.10.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2017] [Revised: 10/15/2017] [Accepted: 10/20/2017] [Indexed: 11/28/2022]

For:	Dam Larsen F, Jespersen S, Wejse C, Petersen E, Larsen CS. One-sixth of inpatients in a Danish infectious disease ward have imported diseases: A cross-sectional analysis. Travel Med Infect Dis 2017;20:43-48. [PMID: 29066404 DOI: 10.1016/j.tmaid.2017.10.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2017] [Revised: 10/15/2017] [Accepted: 10/20/2017] [Indexed: 11/28/2022]

Number

Cited by Other Article(s)

Hønge BL, Hansen KS, Thomsen MK, Østergaard L, Mogensen TH, Storgaard M, Erikstrup C, Sørup S. Validation of ICD-10 diagnostic coding for influenza in the Danish National Patient Registry. Ann Epidemiol 2025;102:62-67. [PMID: 39793861 DOI: 10.1016/j.annepidem.2024.12.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2024] [Revised: 12/28/2024] [Accepted: 12/31/2024] [Indexed: 01/13/2025]

Ekezie W, Awwad S, Krauchenberg A, Karara N, Dembiński Ł, Grossman Z, del Torso S, Dornbusch HJ, Neves A, Copley S, Mazur A, Hadjipanayis A, Grechukha Y, Nohynek H, Damnjanović K, Lazić M, Papaevangelou V, Lapii F, Stein-Zamir C, Rath B, for the ImmuHubs Consortium. Access to Vaccination among Disadvantaged, Isolated and Difficult-to-Reach Communities in the WHO European Region: A Systematic Review. Vaccines (Basel) 2022;10:1038. [PMID: 35891201 PMCID: PMC9324407 DOI: 10.3390/vaccines10071038] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 05/30/2022] [Accepted: 06/14/2022] [Indexed: 01/27/2023] Open

Affiliation(s)

Winifred Ekezie Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany; (W.E.); (S.A.) Department of Epidemiology and Public Health, University of Nottingham, Nottingham NG5 1PB, UK College of Life Sciences, University of Leicester, Leicester LE5 4PW, UK ImmuHubs Consortium, Coordinating Entity: Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany;
Samy Awwad Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany; (W.E.); (S.A.) ImmuHubs Consortium, Coordinating Entity: Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany; Stanford University, Palo Alto, CA 94305, USA
Arja Krauchenberg ImmuHubs Consortium, Coordinating Entity: Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany; European Parents Association, 1000 Brussels, Belgium
Nora Karara Young European Academy of Paediatrics, 1000 Brussels, Belgium; Evangelical Hospital Queen Elisabeth Herzberge, 10365 Berlin, Germany
Łukasz Dembiński European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.) Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, 02-091 Warsaw, Poland
Zachi Grossman European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.) Adelson School of Medicine, Ariel University, Ariel 40700, Israel
Stefano del Torso European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Hans Juergen Dornbusch European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Ana Neves European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Sian Copley European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Artur Mazur European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Adamos Hadjipanayis European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Yevgenii Grechukha European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Hanna Nohynek Finnish Institute for Health and Welfare, FI-00271 Helsinki, Finland;
Kaja Damnjanović Faculty of Philosophy, University of Belgrade, 11000 Beograd, Serbia;
Milica Lazić Faculty of Philosophy, University of Novi Sad, 21000 Novi Sad, Serbia;
Vana Papaevangelou European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Fedir Lapii European Academy of Paediatrics, 1000 Brussels, Belgium; (Ł.D.); (Z.G.); (S.d.T.); (H.J.D.); (A.N.); (S.C.); (A.M.); (A.H.); (Y.G.); (V.P.); (F.L.)
Chen Stein-Zamir Jerusalem District Health Office, Jerusalem 94341, Israel;
Barbara Rath Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany; (W.E.); (S.A.) Department of Epidemiology and Public Health, University of Nottingham, Nottingham NG5 1PB, UK ImmuHubs Consortium, Coordinating Entity: Vienna Vaccine Safety Initiative e.V., 10437 Berlin, Germany;
for the ImmuHubs Consortium

Collapse

Eiset AH, Stensvold CR, Fuursted K, Nielsen HV, Wejse C. High prevalence of methicillin-resistant Staphylococcus aureus, Giardia, and Blastocystis in asymptomatic Syrian asylum seekers in Denmark during 2016 through 2018. J Migr Health 2021;1-2:100016. [PMID: 34405169 PMCID: PMC8352168 DOI: 10.1016/j.jmh.2020.100016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2020] [Revised: 12/02/2020] [Accepted: 12/02/2020] [Indexed: 11/30/2022] Open

Abstract

•

High prevalence of intestinal parasite colonisation; all were asymptomatic.

•

High prevalence of MRSA; low prevalence of ESBL and CPO.

•

Recommend attention to antimicrobial resistance when attending to Syrian refugees.

•

Recommend no routine screening for parasites in asymptomatic adult Syrian refugees.

Introduction

Concerns have been raised regarding the emergence of antimicrobial-resistance and parasitic infections in the European refugee population. Here, we estimated the prevalence of intestinal parasites and selected antimicrobial-resistant bacteria in newly arrived asylum seekers in Denmark.

Materials and methods

Using a cross-sectional one-stage cluster sample design, adult Syrian asylum seekers were included upon arrival in Denmark. Faecal samples were collected and tested for ova and parasites, extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and carbapenemase-producing organisms (CPO). Throat swabs were collected and analysed for methicillin-resistant Staphylococcus aureus (MRSA) and Corynebacterium diphtheriae.

Results

We invited 121 eligible individuals (20% of the source population) from six different asylum centres to participate, of whom 113 agreed. Throat swabs and faecal samples were received from 104 and 48 participants, respectively. Seven individuals did not provide enough material for the entire panel of faecal analyses. Three individuals (7.3%, 95%CI: 2.5–19.4%) were colonised with Giardia intestinalis and 28 (68.3%, 95%CI: 53.0–80.4%) with Blastocystis sp. (subtypes 1 [n = 5], 2 [n = 9] and 3 [n = 14]). Seven individuals (6.7%, 95%CI: 3.3–13.3%) were colonised with MRSA and one with ESBL-E. None had CPO or Corynebacterium diphtheriae and none reported any gastro-intestinal symptoms.

Discussion

Even with the most conservative estimates, the prevalence of Giardia intestinalis, Blastocystis sp. and MRSA was high in this asymptomatic refugee population.

Conclusions

We highlight the importance of raised awareness of antimicrobial-resistant bacteria when attending to newly arrived Syrian refugees. Meanwhile, our data suggest that routine screening for intestinal parasites in this population is of limited clinical relevance.

Collapse

Should travellers be offered vaccination against the dengue virus? Travel Med Infect Dis 2019;27:2-4. [DOI: 10.1016/j.tmaid.2018.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2018] [Revised: 09/17/2018] [Accepted: 09/18/2018] [Indexed: 11/24/2022]